COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults
Clinical trial NCT04710303 · COMPLETED
Trial details
- NCT number
- NCT04710303
- Sponsor
- ImmunityBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-02
- Primary completion
- 2022-08-02
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.